Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Andrei Pop

Interventional Cardiology Elk Grove Village, IL Medical Doctor

NPI 1417156365 CMS profile 18561

800 Biesterfield Rd Ste G01, Elk Grove Village, IL 60007

Open in the dashboard

General payments

$900,283

998 records reported · program years 2019–2025

Research payments

$3,102

Paid to them · 5 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$953,705 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Andrei Pop of Elk Grove Village, IL is reported in the CMS Open Payments database as having received $900,283 across 998 general payments and $3,102 in research payments paid to them. Separately, studies naming them as principal investigator received $953,705 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $317,127 287
2024 General $260,701 229
2023 General $159,347 183
2022 General $116,804 144
2021 General $33,208 78
2021 Research $1,352 3
2020 General $6,299 24
2020 Research $1,751 2
2019 General $6,796 53

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Andrei Pop
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Andrei Pop were reported at $317,127. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Andrei Pop Interventional Cardiology median Middle half National median
2019 $6,796 $1,097 $329–$3,048 $163
2020 $6,299 $473 $161–$1,480 $114
2021 $33,208 $677 $233–$1,827 $132
2022 $116,804 $978 $333–$2,724 $149
2023 $159,347 $1,136 $382–$2,986 $160
2024 $260,701 $1,181 $395–$3,326 $164
2025 $317,127 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Edwards Lifesciences Corporation $852,345 717 payments
  2. Inari Medical, Inc. $16,214 18 payments
  3. Shockwave Medical, Inc $14,587 17 payments
  4. Abbott Laboratories $4,069 60 payments
  5. Stryker Corporation $3,313 6 payments
  6. Ancora Heart, Inc. $2,636 12 payments
  7. Philips Electronics North America Corporation $1,438 12 payments
  8. Boston Scientific Corporation $1,289 55 payments
  9. LivaNova USA, Inc. $915 5 payments
  10. W. L. Gore & Associates, Inc. $802 18 payments
  11. Other $2,674 78 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $667,837 153 payments
  2. Travel and Lodging $98,914 198 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $97,038 16 payments
  4. Food and Beverage $33,923 596 payments
  5. Education $1,770 33 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $800 2 payments
Products named General payments · program years 2019–2025
  1. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $658,803 244 payments
  2. Edwards SAPIEN 3 Ultra Transcatheter Heart Valve $53,827 93 payments
  3. SAPIEN 3 Ultra RESILIA $36,027 90 payments
  4. CT THROMBECTOMY SYSTEM KIT $19,476 22 payments
  5. FLOWTRIEVER CATHETER, S $19,476 22 payments
  6. PASCAL $12,669 25 payments
  7. Vascular Lithotripsy Lithoplasty $8,095 8 payments
  8. Vascular Lithotripsy Lithoplasty $5,595 5 payments
  9. Edwards SAPIEN 3 Transcatheter Heart Valve $2,835 30 payments
  10. AccuCinch $2,636 12 payments
  11. Other $12,153 248 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Cook Research Incorporated $3,102 5 payments

Prescribing to Medicare patients

Part D · data year 2024 · 30 drugs

Part D claims

2,258

Median for Interventional Cardiology: 2,236

Drug cost

$220,893

Median for Interventional Cardiology: $380,412

Branded share of claims

13.4%

Median for Interventional Cardiology: 27.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 96 $110,321
Xarelto Rivaroxaban Brand 32 $49,127
Brilinta Ticagrelor Brand 24 $25,298
Repatha Sureclick Evolocumab Brand 13 $9,452
Atorvastatin Calcium Generic 418 $4,782
Ezetimibe Generic 146 $3,767
Carvedilol Generic 290 $2,782
Metoprolol Succinate Generic 158 $2,648
Rosuvastatin Calcium Generic 110 $1,904
Clopidogrel Clopidogrel Bisulfate Brand 94 $905

The 10 drugs with the highest cost, of 30 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 4,694 Part D prescribers listed as Interventional Cardiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 96 billing codes

Paid by Medicare

$256,618

Medicare's payments for the services billed

Medicare patients

733

Average age 78

Services billed

2,462

346 women, 387 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 65%
Arthritis 54%
Heart failure 47%
Atrial fibrillation 42%
Diabetes 39%
Chronic kidney disease 39%
COPD 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ELIQUIS
  • E.R. Squibb & Sons, L.L.C. $21
$21 96 —
XARELTO
  • Janssen Pharmaceuticals, Inc $19
$19 32 —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

1,003 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record